Participant is known to be positive for Human Immunodeficiency Virus (HIV), Hepatitis B, or Hepatitis C
Negative screening test results for human immunodeficiency virus (HIV), hepatitis B and C; if positive results are not indicative of true active or chronic infection, the subjects can enter the study after discussion with the principal investigator
. Known to be human immunodeficiency virus (HIV) positive, hepatitis B, or hepatitis C positive;
Positive serology for human immunodeficiency virus (HIV) or hepatitis C virus (HCV); presence in the serum of the antigen hemoglobin (HBs)
Has a known history of or screens positive for Human Immunodeficiency Virus (HIV), active chronic or acute Hepatitis B or Hepatitis C.
Known positive for human immunodeficiency virus (HIV) or infectious hepatitis, type A, B or C or active hepatitis
Positive for human immunodeficiency virus (HIV) or hepatitis B or C
Known positive status for human immunodeficiency virus (HIV) and/or active hepatitis B or C.
Positive test for human immunodeficiency virus and/or active hepatitis B or hepatitis C or tuberculosis
Known to be serologically positive for hepatitis B, hepatitis C or human immunodeficiency virus (HIV)
The patient has known positive status for human immunodeficiency virus active or chronic Hepatitis B or Hepatitis C.
Positive for human immunodeficiency virus (HIV) or hepatitis B or C
Positive serology for human immunodeficiency virus (HIV), hepatitis B or hepatitis C
Human immunodeficiency virus (HIV) positive; active hepatitis B or C;
Positive serology for hepatitis B or C, or known human immunodeficiency virus infection (HIV)
Known to be positive for human immunodeficiency virus (HIV) or infectious hepatitis (type B or C)
Is human immunodeficiency virus (HIV) positive or has evidence of active hepatitis C virus or active hepatitis B virus; if initial test shows a positive result, no further testing will be done
Known human immunodeficiency virus (HIV) positive serology or chronically active hepatitis B or C.
Human immunodeficiency virus (HIV) positive; active hepatitis B or C
Active hepatitis B, active hepatitis C, or positive for human immunodeficiency virus (HIV)
Human immunodeficiency virus (HIV) positive; active hepatitis B or C
True positive test results for human immunodeficiency virus (HIV) or hepatitis B or C
Human immunodeficiency virus (HIV) positive; active hepatitis B or C
Known positive status for human immunodeficiency virus (HIV) and/or active hepatitis B or C.
Research participants who have tested human immunodeficiency virus (HIV) positive, or have active hepatitis B or C infection based on testing performed within  weeks of enrollment
Positive for human immunodeficiency virus (HIV), Hepatitis B, or Hepatitis C
Human immunodeficiency virus (HIV) positive; active hepatitis B or C
Patients known to be human immunodeficiency virus (HIV)-positive or have active hepatitis B or C
Known positive for human immunodeficiency virus (HIV) or with known active infectious hepatitis, type A, B or C
Known to be positive for human immunodeficiency virus (HIV) or infectious hepatitis (type B or C)
Positive test for hepatitis B hepatitis C, and / or human immunodeficiency virus (HIV) during screening, or within  months prior to first dose of study treatment
Subject is positive for human immunodeficiency virus (HIV-) chronic or active hepatitis B, or active hepatitis A or C
Chronic hepatitis B or C virus infection, or known human immunodeficiency virus (HIV) positive, that might affect host immunity
Patients known positive for human immunodeficiency virus (HIV), or infectious hepatitis type B or C
Patient is known to be human immunodeficiency virus (HIV) positive, or have chronic or active hepatitis B (core- or surface antigen-positive) or active hepatitis C infection
Subjects with known seropositivity to human immunodeficiency virus (HIV), positive\n             for Hepatitis B, positive for Hepatitis C (antigen positive), or known hepatic\n             cirrhosis
Known human immunodeficiency virus (HIV), hepatitis B or C-positive patients (active, previously treated or both)
Is positive for human immunodeficiency virus (HIV), chronic or active hepatitis B or active hepatitis A or C
The patient has known positive status for human immunodeficiency virus (HIV) active or chronic Hepatitis B or Hepatitis C.
Subjects is positive for human immunodeficiency virus (HIV); chronic or active hepatitis B or active hepatitis A, or C
Positive for human immunodeficiency virus (HIV), Hepatitis B or C
Is positive for human immunodeficiency virus (HIV), chronic or active hepatitis B or active hepatitis A or C
Human papilloma virus-associated cancers\r\n* Histologically proven squamous carcinoma of the anal canal, penile, vaginal, vulva, or refractory cervical cancer with progression or intolerance to at least one treatment regimen including cisplatin or carboplatin will be enrolled; human papilloma virus (HPV) confirmation is not required\r\n* Patients must have metastatic disease not amenable to surgical resection\r\n* If human immunodeficiency virus (HIV)+ positive, all patients infected with human immunodeficiency virus (HIV) and CD+ T cell count >  cells/mm^ may be eligible for study\r\n* Patients co-infected with hepatitis B virus and/or hepatitis C virus may be included in this study provided that their liver function tests remain within the limits listed above; patients must be followed by a hepatologist during the course of this study
Positive human immunodeficiency virus (HIV) or hepatitis B or C
Known positive for human immunodeficiency virus (HIV) or infectious hepatitis, type A, B or C
Subjects with positive human immunodeficiency virus (HIV) or hepatitis C at baseline by self-report
Subjects with positive human immunodeficiency virus (HIV) or hepatitis C at baseline by self report
Known positive for human immunodeficiency virus (HIV) or hepatitis B or C per institutional standard of care
Known positive status for human immunodeficiency virus or active or chronic Hepatitis B or Hepatitis C.
Known positive for human immunodeficiency virus (HIV), chronic or active hepatitis B or C
Known to be human immunodeficiency virus (HIV) positive or has untreated, active hepatitis B.
Positive test for human immunodeficiency virus (HIV) and/or active hepatitis B or hepatitis C or tuberculosis
True positive test results for human immunodeficiency virus (HIV) or hepatitis B or C
Immunocompromised subjects or those with autoimmune conditions, active hepatitis or positive for human immunodeficiency virus (HIV)
Subject is human immunodeficiency virus (HIV) positive or has chronic hepatitis B or hepatitis C virus requiring treatment
Positive test for human immunodeficiency virus (HIV) and/or active hepatitis B or hepatitis C or tuberculosis
Hepatitis B or C or known human immunodeficiency virus (HIV) positive
Known positive serology for the human immunodeficiency virus (HIV), active hepatitis B and/or active hepatitis C.
Known positive for human immunodeficiency virus (HIV) or infectious hepatitis, type A, B or C
Known positive for human immunodeficiency virus (HIV) or infectious hepatitis, type B or C
Known positive test for human immunodeficiency virus (HIV), hepatitis C virus, or acute or chronic hepatitis B infection
Active hepatitis C or positive tests for human immunodeficiency virus (HIV)
Human immunodeficiency virus (HIV) positive patients are not eligible for this protocol; hepatitis B and C positive patients will be evaluated on a case-by-case basis
Patients who are known to be human immunodeficiency virus (HIV), hepatitis B, or hepatitis C positive
Patient is known to be positive for human immunodeficiency virus (HIV) or infectious hepatitis, type A, B, or C
Known positive for human immunodeficiency virus (HIV) or infectious hepatitis, type B (HBV) or C (HCV) or active hepatitis
Positive for HIV (Human Immunodeficiency Virus) or with active hepatitis B and/or C
Is positive for Human Immunodeficiency Virus (HIV) and/or Hepatitis B or C
positive serology for human immunodeficiency virus (HIV), hepatitis B or hepatitis C or have HIV-AIDS, or active hepatitis B or C.
Positive serology for Human Immunodeficiency Virus (HIV) or Hepatitis C Virus (HCV); presence in the serum of the antigens HBs
Positive for human immunodeficiency virus (HIV) or hepatitis B or C
Known positive for human immunodeficiency virus (HIV), chronic or active hepatitis B or active hepatitis A or C
Known or tests positive for human immunodeficiency virus, hepatitis B, or hepatitis C
Known positive for human immunodeficiency virus (HIV) or infectious hepatitis, type A, B or C
Known positive serology for the human immunodeficiency virus (HIV), active hepatitis B and/or hepatitis C.
Known positive serology for the human immunodeficiency virus (HIV), active hepatitis B and/or hepatitis C.
Known to be positive for human immunodeficiency virus (HIV), hepatitis B, or hepatitis C
Known positive serology for the human immunodeficiency virus (HIV), active hepatitis C, and/or active hepatitis B.
The patient has known positive status for human immunodeficiency virus (HIV), active or chronic Hepatitis B or Hepatitis C.
Known positive status for human immunodeficiency virus (HIV) and/or active hepatitis B or C
Known human immunodeficiency virus (HIV), hepatitis B virus, or hepatitis C virus positive status
Patients known to be positive for human immunodeficiency virus (HIV) or infectious hepatitis, type B or C requiring active therapy (hepatitis B seropositivity due to hepatitis [Hep] B virus vaccine is not an exclusion); patients on combination antiviral therapy are ineligible; appropriate studies will be undertaken in this patient population
Human immunodeficiency virus (HIV) positive; active hepatitis B or C
Known chronic active hepatitis B or hepatitis C; human immunodeficiency virus (HIV)-positive patients receiving or are candidates for antiretroviral therapy are also excluded
Positive for human immunodeficiency virus (HIV) or active infections for hepatitis B, and/or hepatitis C, based on medical history
Subjects with positive human immunodeficiency virus (HIV) or hepatitis C at baseline
Subject is positive for human immunodeficiency virus (HIV-), chronic or active hepatitis B, or active hepatitis A or C
Human immunodeficiency virus (HIV) positive or active hepatitis
Documented negative serologic testing for human immunodeficiency virus (HIV), hepatitis B (unless serologically positive due to prior vaccination), and hepatitis C =<  year prior to registration
Is known to be human immunodeficiency virus (HIV) positive and/or known to have active chronic or acute Hepatitis B or Hepatitis C
Known positive test for human immunodeficiency virus (HIV), hepatitis C virus, or acute or chronic hepatitis B infection
